Leal Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Leal Therapeutics?

Leal Therapeutics has 7 investors including Euclidean Capital And Newpath Management.

Q: When was the last funding round for Leal Therapeutics?

Leal Therapeutics closed its last funding round on obfuscated from a Series A round.

Q: How much funding has Leal Therapeutics raised to date?

Leal Therapeutics has raised obfuscated.

Overview

Leal Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Events

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Leal Therapeutics

CB Rank

10789

Leal Therapeutics develops novel therapeutics for patients.

Founded

obfuscation

Private

Series A

Worcester, Massachusetts, United States

11-50

lealtx.com/

Medical

Neuroscience

Therapeutics

Funding Rounds

Series A

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Seed

OBF

obfuscation

Key People

Xianglin Shi: CTO
Asa Abeliovich: Founder and CEO
Past Role: Prevail Therapeutics, Founder and CEO

Details

Legal Name

Leal Therapeutics, LLC

Operating Status

Active

Company Type

For Profit

Founders

Asa Abeliovich

About the Company

Leal Therapeutics develops novel therapeutics for patients.

Predictions & Insights

Growth Insight

See this Growth Insight

Leal Therapeutics is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Key Employee Changes

Products & Services

LTX-002

An antisense oligonucleotide (ASO) therapeutic targeting SPTLC1 to treat ALS, peripheral neuropathy, and Alzheimer’s disease by modulating lipid metabolism.

LTX-001

An oral small molecule targeting GLS1 to treat schizophrenia, major depressive disorder, bipolar disorder, and ALS by modulating glutamate presynaptic activity.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A
obfuscated obfuscation	Series A - Leal Therapeutics	7	obfuscated obfuscation	Dementia Discovery Fund	Series A

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Euclidean Capital	—	Series A - Leal Therapeutics	—
Euclidean Capital	—	Series A - Leal Therapeutics	—
Euclidean Capital	—	Series A - Leal Therapeutics	—
Euclidean Capital	—	Series A - Leal Therapeutics	—
Euclidean Capital	—	Series A - Leal Therapeutics	—